MARSHALL WACE, LLP - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 55 filers reported holding CASI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$241,000
-78.7%
300,508
-68.4%
0.00%
-100.0%
Q3 2021$1,133,000
+226.5%
952,037
+325.6%
0.01%
+150.0%
Q2 2021$347,000
+233.7%
223,709
+618.1%
0.00%
+100.0%
Q3 2019$104,000
+18.2%
31,155
+2.2%
0.00%
Q1 2019$88,00030,4940.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders